ID
35716
Beschrijving
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus; ODM derived from: https://clinicaltrials.gov/show/NCT02229383
Link
https://clinicaltrials.gov/show/NCT02229383
Trefwoorden
Versies (1)
- 17-03-19 17-03-19 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
17 maart 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Diabetes Mellitus NCT02229383
Eligibility Diabetes Mellitus NCT02229383
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Serum calcitonin measurement
Datatype
boolean
Alias
- UMLS CUI [1]
- C0863135
Beschrijving
Pancreatitis | Pancreatitis, Chronic | Triglycerides measurement
Datatype
boolean
Alias
- UMLS CUI [1]
- C0030305
- UMLS CUI [2]
- C0149521
- UMLS CUI [3]
- C0202236
Beschrijving
Hepatitis B Seropositive | Hepatitis C Seropositive
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0019163
- UMLS CUI [1,2]
- C0521143
- UMLS CUI [2,1]
- C0019196
- UMLS CUI [2,2]
- C0521143
Similar models
Eligibility Diabetes Mellitus NCT02229383
- StudyEvent: Eligibility
C0178602 (UMLS CUI [1,2])
C0456683 (UMLS CUI [1,3])
C0009429 (UMLS CUI [2])
C0012159 (UMLS CUI [3])
C0015259 (UMLS CUI [4])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0456683 (UMLS CUI [1,4])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0456683 (UMLS CUI [1,4])
C0038766 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
C0149521 (UMLS CUI [2])
C0202236 (UMLS CUI [3])
C0521143 (UMLS CUI [1,2])
C0019196 (UMLS CUI [2,1])
C0521143 (UMLS CUI [2,2])